Companies

AN2 Therapeutics, Inc. (ANTX) SEC filings

CIK 0001880438 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Net income (USD)-35.2 M-64.7 M-41.0 M
Diluted EPS (USD/shares)-1.16-2.74-2.79

Latest filings

FiledFormDescriptionPeriod
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-10-13442026-10-12
2026-09-16442026-09-15
2026-09-14S-8S-8
2026-09-11442026-09-09
2026-09-08442026-09-03
2026-09-04442026-09-01
2026-09-02442026-09-01
2026-08-27332026-08-24
2026-08-19442026-08-17
2026-08-17144144
2026-08-14442026-08-14
2026-08-1110-Q10-Q2026-06-30
2026-08-118-K8-K items 2.02,9.012026-08-11
2026-07-10442026-07-10
2026-07-10442026-07-10
2026-07-10442026-07-10
2026-07-10442026-07-08
2026-06-098-K8-K items 5.072026-06-03
2026-06-048-K8-K items 7.01,8.01,9.012026-06-04
2026-06-02442026-05-29
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1110-Q10-Q2026-03-31
2026-05-118-K8-K items 2.02,9.012026-05-11

Forms on file (last 1,000): 4 186, 8-K 40, 3 21, SC 13G/A 15, 144 14, 10-Q 14, SC 13G 12, SCHEDULE 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=ANTX (0.002 USD), /gw/filings/filings?ticker=ANTX&form=8-K, /gw/filings/facts?ticker=ANTX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange